We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

32 hedge funds and large institutions have $61.2M invested in Avadel Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $110K | Put options by funds: $75K

Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
–
Reduced
–
Closed
–
Calls
$110K
Puts
$75K
Net Calls
+$35K
Net Calls Change
+$35K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$26.6M +$22.4M +4,333,475 New
BC
2
Broadfin Capital
New York
$19.3M +$16.2M +3,139,131 New
CLM
3
ClearBridge LLC (Maryland)
Maryland
$3.65M +$3.07M +595,053 New
BCM
4
Brown Capital Management
Maryland
$3.17M +$2.67M +516,295 New
Bank of New York Mellon
5
Bank of New York Mellon
New York
$1.38M +$1.16M +225,437 New
BI
6
BVF Inc
California
$931K +$782K +151,406 New
Invesco
7
Invesco
Georgia
$903K +$760K +147,068 New
IAM
8
Iridian Asset Management
Connecticut
$756K +$636K +123,170 New
Morgan Stanley
9
Morgan Stanley
New York
$697K +$587K +113,607 New
Deutsche Bank
10
Deutsche Bank
Germany
$694K +$585K +113,178 New
CCI
11
Columbus Circle Investors
$485K +$408K +79,011 New
U
12
UBS
Switzerland
$442K +$372K +71,970 New
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$432K +$363K +70,274 New
Millennium Management
14
Millennium Management
New York
$371K +$312K +60,490 New
CCM
15
Condor Capital Management
New Jersey
$296K +$249K +48,186 New
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$223K +$187K +36,238 New
EVM
17
Eaton Vance Management
Massachusetts
$213K +$179K +34,700 New
BWP
18
Baldwin Wealth Partners
Massachusetts
$176K +$148K +28,750 New
SNC
19
Stifel Nicolaus & Co
Missouri
$79.8K +$67.1K +13,000 New
US Bancorp
20
US Bancorp
Minnesota
$77K +$64.6K +12,500 New
OAM
21
Oxford Asset Management
United Kingdom
$74K +$62.4K +12,089 New
FIM
22
Freedom Investment Management
Connecticut
$74K +$62.6K +12,112 New
JMFC
23
J.M. Forbes & Co
Massachusetts
$68K +$56.8K +11,000 New
Group One Trading
24
Group One Trading
Illinois
$38K +$31.8K +6,160 New
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$37K +$31K +6,000 New
1
2

AVDL Hedge Fund Activity: Q2 2013 in Review

32 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2013, worth a combined $61.2M.

Buyers outnumbered sellers: 32 funds opened new AVDL positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

  • 32 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $61.2M of Avadel Pharmaceuticals stock for Q2 2013.
  • 32 funds opened new Avadel Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +32 holders.

Based on aggregated 13F filings for Q2 2013.